Market Size & Trends
The size of the global clinical decision support systems market was valued at USD 5.79 billion in 2024 and is expected to grow at a CAGR of 11.0% during the period 2025-2030. Clinical decision support systems have seen remarkable development in the past few decades, empowering clinicians with critical tools for making educated decisions in patient care. They have shown great potential in enhancing patient outcomes and lowering healthcare costs overall.
AI and ML technologies are revolutionizing the CDSS market, providing sophisticated capabilities like predictive analytics, pattern recognition, and personalized recommendations. AI-based CDSSs have the ability to scrutinize large datasets, identify patterns, predict outcomes, and recommend best treatment plans. Researchers are combining AI with CDSS, as evidenced by the University of Texas at Austin's Dell Medical School researchers who created an AI-based CDSS to support clinicians in discussing nutrition and deciding with patients regarding diet improvements in December 2022.
The use of personalized medicine is on the rise, with CDSSs being an important factor. CDSSs examine patient information, such as genetic data and medical histories, to tailor treatment plans to the individual patient. With the provision of individualized recommendations, CDSSs improve the efficacy of treatments and decrease the chances of side effects, fueling market expansion.
Governments across the globe are enacting regulations and incentives to encourage CDSS and other healthcare IT solutions. These regulations aim to improve patient safety, interoperability, and quality of care, which encourages healthcare organizations to invest in CDSS to meet regulatory needs and become eligible for incentives.
The COVID-19 pandemic has also contributed positively to the market growth, resulting in higher adoption of CDSS. CDSSs have played a key role in patient resources and services support, as evidenced by their application in real-time clinical COVID-19 diagnosis and patient triage. Different nations with online services offered have additionally driven market growth. Players within the market have launched CDSSs for COVID-19 data and insight management. For example, in May 2022, Epocrates introduced a groundbreaking tool for long COVID-19, which incorporated the newest updates to grow the library of clinical decision support guidelines. In turn, heightened adoption and entry of clinical decision support systems have driven market growth amid the pandemic.
Report Coverage & Deliverables
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
AI-Driven Clinical Decision Support Systems Market
Researchers are incorporating AI into Clinical Decision Support Systems (CDSS) to analyze enormous data to suggest treatment options, identify possible problems, automate processes, and assist healthcare providers. Therefore, researchers are merging CDSS with AI. In December 2022, University of Texas at Austin's Dell Medical School researchers developed an AI-driven CDSS to help clinicians discuss nutrition and share decision-making with patients regarding diet enhancement.
Using patient health information, such as data from electronic health records (EHRs), clinical decision support systems powered by AI increase the precision of treatment, diagnosis, and prognosis for certain medical conditions. Such systems forecast medical results or estimate disease risks with the aid of biomedical image information. AI CDSS can evaluate past, existing, and incoming patient information to determine safety issues, mistakes, or potential ways of improving care pathways. Their accurate prediction power creates novel paths for better patient care.
Market Concentration & Traits
The degree of innovation in the clinical decision support systems industry is high. The innovation involves the integration of advanced technologies like artificial intelligence (AI) and machine learning (ML), as well as regular updates to features aimed at enhancing operational efficiency. In November 2023, for instance, GE HealthCare launched AI models that forecast patient response to immunotherapies. They are likely to be used in clinical decision support and pharmaceutical drug development.
The level of M&A activity is intense in the market. The market participants employ different strategies such as mergers & acquisitions, collaborations, and new product releases to develop their product portfolio, thereby contributing to the growth of the market. For instance, in October 2022, Beckman Coulter Diagnostics made a purchase of StoCastic, LLC., an entity that delivers evidence-based decision support to emergency departments (ED) in hospitals. Through the acquisition, Beckman Coulter Diagnostics' CDSS portfolio will likely be strengthened.
The industry of CDSS is regulated by regulatory bodies, for instance, the FDA. For instance, in September of 2022, the final and revised guide documents were published by the U.S. FDA, e.g., Final CDS Guidance, for clinical decision support software, among other digital health issues.
Major players are focusing on geographical expansion to grab new geographical CDSS industries. Expansion is typically done by establishing manufacturing facilities or R&D facilities in new geographies or acquisition and merger of overseas companies.
Product Insights
Standalone CDSS maintained the largest share of the market at 30.7% in 2024, due to widespread usage for its low cost and ease. They do not need standardization or high clinical expertise and can function without actual patient data. Their ease of use accounts for dominance in hospitals and clinics.
The combined EHR with CDSS segment is anticipated to develop at the highest CAGR over the forecast period, supported by growing EHR adoption across multi-specialty healthcare centers. Integrated systems grant CDSSs access to patient databases and medical histories, and automate clinical processes. In April 2023, the U.S. government issued a rule providing providers greater comprehensive access to information within their EHR systems to assess CDSS algorithms and results. Integration of CDSSs with EHRs standardizes workflows and takes advantage of existing datasets. Furthermore, additional CDSS functions are integrated into EHR systems, enabling segment growth.
Application Insights
Drug allergy alerts held the highest market share of 25.7% in 2024. Allergies to certain drugs are present in many individuals, and hence it is essential to possess systems that offer allergy alerts. because it is extensively used in clinical decision support systems (CDSSs) to maintain patient safety and avoid adverse drug reactions (ADRs). CDSSs permit customization of allergy alerts according to individual patient profiles and certain allergy details. Healthcare professionals can customize alert levels and preferences to make alerts meaningful and actionable for every patient. The increasing drug allergy burden is propelling CDSS adoption, which is influencing the growth of the segment. For instance, roughly 10% of the population in the U.S. is penicillin-allergic, as per the CDC.
The clinical guidelines segment will register the highest CAGR throughout the forecast period. Clinical Decision Support (CDS) systems offer decision support for treatment and diagnosis, offering critical real-time information primarily at the time of care. They automate the mundane tasks, warn clinical staff of potential problems, and give recommendations for monitoring healthcare professionals and patients. For example, Clinical Decision Support is defined by the American Medical Informatics Association (AMIA) as a process to improve health-related decision-making and actions that enables clinicians, patients, and stakeholders to improve clinical decision-making processes and the quality of healthcare services and patient outcomes.
Component Insights
CDSS services commanded the largest market share of 42.3% during 2024, as it provides implementation, training, support, customization, and consulting services to enable healthcare organizations to maximize CDSS software value and streamline clinical decision-making. This segment led the market as ongoing technical support guarantees CDSS performance and functionality. Furthermore, healthcare professionals need training to properly use CDSS, further driving segment growth.
CDSS software segment is expected to advance at the highest CAGR over the forecast period. The CDSS software, when combined with software for CPOE and EHRs, offers added decision support by rendering personalized and unique results for the specific patient. Newer innovations in technical support, software interoperability, and effective outcomes are expected to propel the market over the forecast years. For example, in July 2022, QIAGEN reported that its CDS software platform, QIAGEN Clinical Insights (QCI), was used to process more than three million patient molecular profiles for oncologic and hereditary conditions.
Delivery Mode Insights
On-premise segment in delivery mode held the highest market share of 41.9% in 2024. On-premise CDSS solutions provide flexibility to customize and integrate with current healthcare systems and workflows according to specific organizational requirements. Multispecialty hospitals and large healthcare organizations utilize this system for better control over data within their infrastructure. Existing systems such as EHRs can be integrated, which allows easier flow of data and interoperability, providing efficiency in decision support.
Cloud systems are projected to develop at the highest CAGR during the forecast period. A major IT development, they are characterized by cost savings and reliability. Greater access through mobile devices and powerful data protection solutions promote their adoption. In contrast to web-based systems, cloud solutions do not rely on web browsers, making them more secure and user-friendly.
Regional Insights
North America clinical decision support systems market dominated the global market with over 43.10% revenue share in 2024.This dominance is fueled by the rising demand for IT solutions in healthcare and the emphasis on delivering quality healthcare services. Rapid technological advancements further drive market growth. Initiatives promoting CDSS adoption, like EBSCO Information Services' Dyna Innovation Center launch in December 2023, contribute to regional market expansion. For example, in December 2023, EBSCO Information Services launched Dyna Innovation Center in the U.S. to drive innovation in clinical decision-making. Thus, the aforementioned efforts by the market players are likely to boost the growth of the region's CDSS market.
U.S. Clinical Decision Support Systems Market Trends
CDSS market in the U.S. occupied the highest market share in 2024. The growth is fueled by the rising adoption of EHRs among hospitals and healthcare institutions. For example, as per the Office of the National Coordinator for Health Information Technology, in 2021, about 78% of doctors and 96% of hospitals utilized a certified EHR.
Europe Clinical Decision Support Systems Market Trends
Europe CDSS market is likely to hold a significant market share during the forecast period. It is because of the presence of major market players, rising usage of CDSS, and conducive frameworks. For example, the European Commission released a document in February 2024 to highlight and encourage the use of clinical decision support tools.
Clinical decision support systems UK market is likely to expand remarkably with the rising adoption of sophisticated healthcare IT solutions. Likewise, effective collaborations between healthcare and IT sectors in the UK and governmental initiatives is likely to drive the nation's market growth. For example, the UK government has announced about USD 22.7 million funding in June 2023 for the deployment of AI-based decision support systems to make early diagnosis of strokes, cancers, and heart conditions.
Asia Pacific Clinical Decision Support Systems Market Trends
Asia Pacific CDSS market is anticipated to record the highest CAGR within the forecast period. The reason behind this growth is the rising investments in healthcare sectors across nations like China, Japan, India, and Australia. Asia Pacific's market is reflecting great potential with increasing R&D spending by governments of major regional economies to enhance information technology penetration in the healthcare industry. A few of the prominent players in this market include MedPac Systems Solutions India LLP, Allscripts Healthcare Solutions, Inc., Practo, Cerner Corp., and Koninklijke Philips N.V.
Australia clinical decision support systems market is predominantly fueled by the growing uptake and advocacy of CDSS, particularly by government agencies. For example, in April 2022, Northern Territory (NT) Health partnered with Alcidion to access the sophisticated Miya Precision CDS platform. NT Health will implement the CDS platform in its five public hospitals and remote and community health centers that provide care to over 200,000 individuals. The CDS platform was supposed to assist the network's bed and patient flow management in NT hospitals and satellite facilities.
China clinical decision support systems market is anticipated to grow at a high CAGR due to various business strategies adopted by the market players. For example, in June 2023, AffaMed Therapeutics released Headache CDSS in collaboration with the International Headache Center of the Chinese PLA General Hospital at the 16th Annual Meeting of Neurologists of the Chinese Medical Association.
Key Clinical Decision Support Systems Company Insights
The global CDSS market is fairly competitive. The most notable participants in the market are McKesson Corporation; Philips Healthcare; Wolters Kluwer NU; Cerner Corporation; Siemens Healthineers, along with other providers of clinical decision support systems. These players are involved in new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other.
Key Clinical Decision Support Systems Companies
The following are the leading companies in the clinical decision support systems market. These companies collectively hold the largest market share and dictate industry trends.
- McKesson Corporation
- Cerner Corporation
- Siemens Healthineers GmbH
- Allscripts Healthcare, LLC
- athenahealth, Inc.
- NextGen Healthcare Inc.
- Koninklijke Philips N.V. (Royal Philips)
- IBM Corporation
- Agfa-Gevaert Group
- Wolters Kluwer N.V.
- Becton, Dickinson and Company
- Cabot Technology Solutions
- GE HealthCare
- Nordic
- BeeKeeperAI
- BSCO Industries, Inc.
Recent Developments
-
In April 2025, Becton, Dickinson and Company debuted next-generation HemoSphereAdvanced Monitoring Platform, with AI-powered clinical decision support to augment real-time hemodynamic monitoring.
In December 2023, EBSCO Information Services debuted the Dyna Innovation Center in the United States to foster innovation such as the deployment of AI, in clinical decisions
In October 2023, Wolters Kluwer Health introduced AI Labs, a shared resource to combine generative AI with UpToDate, its CDS solution, for better-informed decisions by medical professionals.
In August 2023, GE HealthCare released CardioVisio for Atrial Fibrillation, patient-focused, digital CDS software to facilitate precision care.
In February 2023, EBSCO Information Services introduced new features in DynaMedex Mobile App to enhance clinical decision support. The enhancements enhance the mobile experience of the users by allowing clinicians to provide evidence-based patient care in an efficient manner.
In May 2020, DHIndia made an announcement about collaborating with EHRC@IIITB & Healthelife to create a CDSS for screening COVID-19. The collaboration also involved creating a minimal triage application for front-line physicians. Some of the key players in the market for clinical decision support systems worldwide are
In March 2020, IBM Watson Health collaborated with EBSCO Information Services to improve CDSS and operations for healthcare providers and systems.
Clinical Decision Support Systems MarketReport Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 6.36 billion |
|
Revenue forecast in 2030 |
USD 10.71 billion |
|
Growth rate |
CAGR 11.0% from 2025 to 2030 |
|
Actual data |
2018 - 2024 |
|
Forecast period |
2025 - 2030 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Product, application, delivery mode, component, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; MiddleEast and Africa |
|
Country scope |
U.S.; Canada; Germany; UK; France; Italy; Spain; Norway, Sweden, Denmark, Japan; India; China; Australia; Thailand; South Korea; Brazil; Mexico; Argentina, South Africa; Saudi Arabia; UAE; Kuwait |
|
Key companies profiled |
McKesson Corporation; Cerner Corporation; Siemens Healthineers GmbH; Allscripts Healthcare, LLC; athenahealth, Inc.; NextGen Healthcare Inc.; Koninklijke Philips N.V. (Royal Philips); IBM Corporation; Agfa-Gevaert Group; Wolters Kluwer N.V.; Becton, Dickinson and Company; Cabot Technology Solutions; GE HealthCare; Nordic; BeeKeeperAI; BSCO Industries, Inc. |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail of customized purchase options to meet your exact research needs. Explore purchase options |
Global Clinical Decision Support Systems Market Report Segmentation
Product Outlook (Revenue, USD Million, 2018 - 2030)
-
-
Standalone CDSS
-
Integrated CPOE with CDSS
-
Integrated EHR with CDSS
-
Integrated CDSS with CPOE & EHR
-
-
Application Outlook (Revenue, USD Million, 2018 - 2030)
-
Drug-drug interactions
-
Drug allergy alerts
-
Clinical reminders
-
Clinical guidelines
-
Drug dosing support
-
Others
-
-
Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)
-
Web-based Systems
-
Cloud-based Systems
-
On -premise Systems
-
-
Component Outlook (Revenue, USD Million, 2018 - 2030)
-
Hardware
-
Software
-
Services
-
-
Regional Outlook (Revenue, USD Million, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
Italy
-
Spain
-
France
-
Sweden
-
Denmark
-
Norway
-
RoE
-
-
Asia Pacific
-
China
-
India
-
Japan
-
Thailand
-
South Korea
-
Australia
-
RoAPAC
-
-
Latin America
-
Brazil
-
Argentina
-
RoLATM
-
-
MEA
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
RoMEA
-
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy